HTDS receives Registration Certificate for MEVAC-Vari vaccine in Guatemala

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its subsidiary Mellow Hope announce that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala.

This is the first Final Approval for HTDS' Varicella vaccine in South America. In general, doctors regard Varicella, commonly known as chickenpox, as a mild viral illness. However, approx. 1 in 50 cases chickenpox associates with complications such as pneumonia and encephalitis, and both diseases report high mortality rate.

A source close to HTDS said, "Varicella complications can be averted by a simple vaccination, and we are happy that we obtained the Registration Certificate for our Freeze-dried Varicella vaccine (Mevac-Vari) in Guatemala. As it is Mellow Hope's first Final Approval in South America, we see it as an important step and a very good start for our Varicella vaccine on the South American market. South America offers great potential for our affordable vaccines and our representatives continue their work to deliver Mellow Hope's vaccines to the developing world."

In other company news the HTDS management has learned that on line brokerage Scottrade has lifted restrictions for on line buys on HTDS as the oversold issue is being resolved. The company expects other online brokerages to shortly follow similarly.

The company reminds our shareholders and followers to monitor PinkSheets.com Filing Section and also our IR company web site section "PRESS RELEASES AND FILINGS" TAB http://www.minamargroup.net/. Non-newsworthy events are not press released however posted on these two separate support sites to keep our followers advised of day-to-day events. For any matters relating to retail investor queries or to send us the company directly a message please click on the "INVESTOR SUPPORT" TAB or this direct link http://www.minamargroup.net/helpdesk.

Don't be a victim. Report a stock basher. The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas, where amongst other things they continuously spread false rumors, dark propaganda and innuendos in order to manipulate the trading patterns and thwart company plans for their own "quick profits" and self serving needs. The company and its supporters are monitoring these activities and those are promptly being reported on the http://www.stockbasher.com website. Visit http://www.stockbasher.com and find out what criminal and civil actions the US authorities are taking against web sites like investorshub.com and other posters, and other media that provide safe refuge to these individuals and the remedies available to you as an individual investor.

Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support Section in due course. To be included in company's email database for press releases, industry updates, and non-weekly activity at the company that may or may not be news released, please subscribe or opt in mailer at http://www.minamargroup.com/updates.

Source:

Hard to Treat Diseases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Argonne receives $21.7 million to advance cancer and vaccine discoveries